Our results suggested that patients who died within 3 months after surgery were significantly associated with preoperatively worsened liver function, such as total bilirubin or ascites, compared with those who survived beyond the first 3 months, while patients surviving for > 2 years after surgery were associated with CSPH and factors of tumor aggressive nature, such as tumor differentiation, AFP and extent of PVTT. Here, AFP is linked to Ascites.